16-20c is a fair price given market conditions. I would even argue that they are cheap given that IPO was 20c and that was 12 mths ago when they didn't even have manufacturing going nor any approvals.
They now have FDA approval, trials in Germany, USA, Latin America, India so it's actually quite a cheap price.
Things get very exciting once USA or/and Germany results come in or when more sales get booked in.
A friend of mine works in obstetrics in Oz - they are already seeing a high degree of anxiety amongst expecting mothers.
tick..tick tick.
16-20c is a fair price given market conditions. I would even...
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
